Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 26;9(3):e93053.
doi: 10.1371/journal.pone.0093053. eCollection 2014.

High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus

Affiliations

High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus

Johan F Paulsson et al. PLoS One. .

Abstract

Aims/hypothesis: Islet amyloid polypeptide (IAPP) is a beta cell hormone secreted together with insulin upon glucose stimulation. IAPP participates in normal glucose regulation, but IAPP is also known for its ability to misfold and form islet amyloid. Amyloid fibrils form through smaller cell toxic intermediates and deposited amyloid disrupts normal islet architecture. Even though IAPP and amyloid formation are much discussed in type 2 diabetes, our aim was to study the significance of IAPP in type 1 diabetes.

Results: Plasma IAPP levels in children and adolescents with newly diagnosed type 1 diabetes (n = 224) were analysed and concentrations exceeding 100 pmol/L (127.2-888.7 pmol/L) were found in 11% (25/224). The IAPP increase did not correlate with C-peptide levels.

Conclusions/interpretation: Plasma levels of IAPP and insulin deviate in a subpopulation of young with newly-diagnosed type 1 diabetes. The determined elevated levels of IAPP might increase the risk for IAPP misfolding and formation of cell toxic amyloid in beta cells. This finding add IAPP-aggregation to the list over putative pathological factors causing type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Elevated IAPP values in Day1 samples remain elevated in Day 3 samples.
Comparison of IAPP concentrations in plasma taken at diagnosis (day 1) and three days after diagnosis (day 3). Red circles designate day 1 samples and blue circles day 3 samples.
Figure 2
Figure 2. Comparison of IAPP and C-peptide concentrations in plasma from young with newly diagnosed T1D.
Figure 3
Figure 3. There is no correlation between presence of insulin autoantibodies and plasma IAPP concentration.
Analysis of insulin autoantibodies in plasma from children and adolescent newly diagnosed with T1D.
Figure 4
Figure 4. Analysis of autoantibody reactivity against NIAPP, IAPP and IAPPC in plasma from newly diagnosed T1D.
High IAPP values are represented by blue bars and low IAPP values are represented by purple bars.

References

    1. Lernmark A (1999) Type 1 diabetes. Clin Chem 45: 1331–1338. - PubMed
    1. Yoon JW, Jun HS (2005) Autoimmune destruction of pancreatic beta cells. Am J Ther 12: 580–591. - PubMed
    1. In't Veld P, Lievens D, De Grijse J, Ling Z, Van der Auwera B, et al. (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56: 2400–2404. - PubMed
    1. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155: 173–181. - PMC - PubMed
    1. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, et al. (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360. - PubMed

Publication types